Cohance Lifesciences Limited - Neraca (Quarterly)

Cohance Lifesciences Limited
IN ˙ NSEI
Talaan ng Balanse (Quarterly)

Neraca Cohance Lifesciences Limited menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2021
03-31
2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2023
12-31
2024
03-31
2024
09-30
2025
03-31
Cash 165 72 199 446 850 648 608 7,535 472 368 854
Change (%) -56.53 177.38 123.69 90.73 -23.76 -6.17 1,139.19 -93.73 -22.04 131.94
Assets Current 4,790 5,648 7,298 11,279 9,225 10,110 11,691 11,331 12,532 11,676 8,886
Change (%) 17.92 29.22 54.55 -18.21 9.60 15.63 -3.08 10.60 -6.83 -23.90
Assets 13,183 14,745 16,625 18,296 18,060 19,657 21,198 20,579 22,549 25,056 30,318
Change (%) 11.84 12.75 10.05 -1.29 8.84 7.84 -2.92 9.57 11.12 21.00
Liabilities 3,084 2,937 3,050 3,024 3,030 2,306 1,844 765 2,042 4,771 11,911
Change (%) -4.78 3.86 -0.85 0.18 -23.90 -20.03 -58.51 166.98 133.62 149.64
Equity 10,100 11,808 13,575 15,272 15,031 17,352 19,354 19,814 20,507 20,284 18,406
Change (%) 16.92 14.96 12.50 -1.58 15.44 11.54 2.38 3.50 -1.09 -9.26
Liabilities And Stock Equity 13,183 14,745 16,625 18,296 18,060 19,657 21,198 20,579 22,549 25,056 30,318
Change (%) 11.84 12.75 10.05 -1.29 8.84 7.84 -2.92 9.57 11.12 21.00

Source: Capital IQ

Other Listings
IN:543064
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista